Blue Capital Reinsurance Stock EBITDA
BCRHFDelisted Stock | USD 0.0002 0.00 0.00% |
Blue Capital Reinsurance fundamentals help investors to digest information that contributes to Blue Capital's financial success or failures. It also enables traders to predict the movement of Blue Pink Sheet. The fundamental analysis module provides a way to measure Blue Capital's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Blue Capital pink sheet.
Blue |
Blue Capital Reinsurance Company EBITDA Analysis
Blue Capital's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Blue Capital EBITDA | (28.6 M) |
Most of Blue Capital's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Blue Capital Reinsurance is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Blue Capital Reinsurance reported earnings before interest,tax, depreciation and amortization of (28.6 Million). This is 100.05% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The ebitda for all United States stocks is 100.73% higher than that of the company.
Blue EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Blue Capital's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Blue Capital could also be used in its relative valuation, which is a method of valuing Blue Capital by comparing valuation metrics of similar companies.Blue Capital is currently under evaluation in ebitda category among its peers.
Blue Fundamentals
Return On Equity | -0.27 | |||
Return On Asset | -0.12 | |||
Profit Margin | (0.91) % | |||
Operating Margin | (0.91) % | |||
Current Valuation | 799.38 K | |||
Shares Outstanding | 8.77 M | |||
Shares Owned By Institutions | 16.41 % | |||
Number Of Shares Shorted | 3.65 K | |||
Price To Earning | (1.55) X | |||
Price To Book | 0.01 X | |||
Price To Sales | 0.03 X | |||
Revenue | 35.4 M | |||
Gross Profit | (24.1 M) | |||
EBITDA | (28.6 M) | |||
Net Income | (28.6 M) | |||
Cash And Equivalents | 3 M | |||
Cash Per Share | 0.34 X | |||
Total Debt | 4 M | |||
Debt To Equity | 0.99 % | |||
Current Ratio | 2.84 X | |||
Book Value Per Share | 10.36 X | |||
Cash Flow From Operations | 100 K | |||
Short Ratio | 0.10 X | |||
Earnings Per Share | (3.29) X | |||
Beta | 1.01 | |||
Market Capitalization | 799.38 K | |||
Total Asset | 163.3 M | |||
Retained Earnings | (70.11 M) | |||
Annual Yield | 0.49 % | |||
Five Year Return | 9.07 % | |||
Net Asset | 163.3 M | |||
Last Dividend Paid | 0.6 |
About Blue Capital Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Blue Capital Reinsurance's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Blue Capital using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Blue Capital Reinsurance based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Blue Pink Sheet
If you are still planning to invest in Blue Capital Reinsurance check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Blue Capital's history and understand the potential risks before investing.
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |